Title : Daclatasvir combined with peginterferon-α and ribavirin for the treatment of chronic hepatitis C: a meta-analysis.

Pub. Date : 2016

PMID : 27652142






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Subgroup analysis showed the rate of RVR and SVR24 in high-dose daclatasvir (60 mg/day) group were slightly higher than the overall results; the rate of RVR in low-dose daclatasvir (10 mg/day) group was also higher than the control group, but its SVR24 rate was similar between the two groups. daclatasvir nuclear receptor subfamily 1 group D member 2 Homo sapiens
2 Subgroup analysis showed the rate of RVR and SVR24 in high-dose daclatasvir (60 mg/day) group were slightly higher than the overall results; the rate of RVR in low-dose daclatasvir (10 mg/day) group was also higher than the control group, but its SVR24 rate was similar between the two groups. daclatasvir nuclear receptor subfamily 1 group D member 2 Homo sapiens